Royal Bank of Canada’s AIM ImmunoTech AIM Stock Holding History
Bought
Maintained
Sold
Other funds holding AIM
CB
HI
HI
DB
Royal Bank of Canada's AIM Position: Q2 2025 in Review
Royal Bank of Canada sold out of AIM ImmunoTech (AIM) in Q2 2025, closing a stake of 6 shares.
Royal Bank of Canada first reported a position in AIM in Q1 2020 and held it in 8 quarters. The position peaked at $5K in Q1 2020. 12 funds tracked by Wall St. Rank hold AIM as of Q2 2025.
- Royal Bank of Canada reported no remaining AIM ImmunoTech position as of Q2 2025 after selling out during the quarter.
- Royal Bank of Canada sold 6 AIM ImmunoTech shares in Q2 2025.
- Royal Bank of Canada first reported a position in AIM ImmunoTech in Q1 2020 and held it in 8 quarters.
- Royal Bank of Canada's AIM ImmunoTech position peaked at $5K in Q1 2020.
- 12 funds tracked by Wall St. Rank held AIM ImmunoTech as of Q2 2025.
Based on Royal Bank of Canada's 13F filing for Q2 2025, filed 14 Aug 2025.